VPS4A Antikörper (AA 1-120)
-
- Target Alle VPS4A Antikörper anzeigen
- VPS4A (Vacuolar Protein Sorting-Associated Protein 4A (VPS4A))
-
Bindungsspezifität
- AA 1-120
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser VPS4A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), ELISA
- Kreuzreaktivität
- Human, Maus, Ratte
- Aufreinigung
- Antigen Affinity Purified
- Immunogen
- Recombinant Human Vacuolar protein sorting-associated protein 4A protein (1-120AA)
- Isotyp
- IgG
-
-
- Applikationshinweise
- Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- PBS with 0.02 % sodium azide, 50 % glycerol, pH 7.3.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- VPS4A (Vacuolar Protein Sorting-Associated Protein 4A (VPS4A))
- Andere Bezeichnung
- VPS4A (VPS4A Produkte)
- Synonyme
- vsp4 antikoerper, SKD1 antikoerper, SKD1A antikoerper, SKD2 antikoerper, VPS4 antikoerper, VPS4-1 antikoerper, zgc:153907 antikoerper, 4930589C15Rik antikoerper, AI325971 antikoerper, AW553189 antikoerper, vacuolar protein sorting 4 homolog A antikoerper, vacuolar sorting protein 4 antikoerper, vacuolar protein sorting 4 homolog A L homeolog antikoerper, vacuolar protein sorting 4a homolog A (S. cerevisiae) antikoerper, vacuolar protein sorting 4A antikoerper, VPS4A antikoerper, TP03_0351 antikoerper, vps4a antikoerper, vps4a.L antikoerper, Vps4a antikoerper
- Hintergrund
-
Background: Involved in late steps of the endosomal multivesicular bodies (MVB) pathway. Recognizes membrane-associated ESCRT-III assemblies and catalyzes their disassembly, possibly in combination with membrane fission. Redistributes the ESCRT-III components to the cytoplasm for further rounds of MVB sorting. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. In conjunction with the ESCRT machinery also appears to function in topologically equivalent membrane fission events, such as the terminal stages of cytokinesis and enveloped virus budding (HIV-1 and other lentiviruses). Involved in cytokinesis: retained at the midbody by ZFYVE19/ANCHR and CHMP4C until abscission checkpoint signaling is terminated at late cytokinesis. It is then released following dephosphorylation of CHMP4C, leading to abscission (PubMed:24814515). VPS4A/B are required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413).
Aliases: hVPS4 antibody, Protein SKD2 antibody, SKD1 antibody, SKD1 homolog antibody, SKD1A antibody, SKD2 antibody, Vacuolar protein sorting 4 homolog A antibody, Vacuolar protein sorting 4, yeast, homolog of, A antibody, Vacuolar protein sorting factor 4A antibody, Vacuolar protein sorting-associated protein 4A antibody, vacuolar sorting protein 4 antibody, VPS4 antibody, VPS4-1 antibody, Vps4a antibody, VPS4A_HUMAN antibody
- UniProt
- Q9UN37
- Pathways
- Microtubule Dynamics, CXCR4-mediated Signaling Events
-